Tin tức & Cập nhật
Xem bài viết Sản phụ khoa
Xem
Chỉ hiển thị Multimedia

Toripalimab plus bevacizumab, SoC demonstrates promising efficacy for cervical cancer
15 May 2023
bởiAudrey Abella
Preliminary results of a single-arm, open-label, phase II trial demonstrated the efficacy of a combination regimen comprising toripalimab, bevacizumab, and platinum-based chemotherapy for women with refractory, recurrent, or metastatic cervical cancer.
15 May 2023

Temporary ET break for pregnancy safe in the short term for breast cancer survivors
09 May 2023
bởiChristina Lau
Temporary interruption of adjuvant endocrine therapy (ET) to allow for pregnancy has demonstrated short-term safety, with no increase in risk of breast cancer events, including distant recurrence, in hormone receptor–positive breast cancer survivors who have completed 18–30 months of adjuvant ET.
09 May 2023






